Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
about
Use of Reporter Genes in the Generation of Vaccinia Virus-Derived VectorsInduction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.Vaccinia virus E3 protein prevents the antiviral action of ISG15Differential induction of apoptosis, interferon signaling, and phagocytosis in macrophages infected with a panel of attenuated and nonattenuated poxviruses.Recombinant vaccinia viruses expressing GP46/M-2 protect against Leishmania infectionVaccinia virus vectors: new strategies for producing recombinant vaccines.Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.Distinct gene expression profiling after infection of immature human monocyte-derived dendritic cells by the attenuated poxvirus vectors MVA and NYVAC.Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria.Insertional inactivation of the vaccinia virus 32-kilodalton gene is associated with attenuation in mice and reduction of viral gene expression in polarized epithelial cells.A single point mutation of Ala-25 to Asp in the 14,000-Mr envelope protein of vaccinia virus induces a size change that leads to the small plaque size phenotype of the virus.Attenuated and replication-competent vaccinia virus strains M65 and M101 with distinct biology and immunogenicity as potential vaccine candidates against pathogens.Smallpox vaccines for biodefense.The vaccinia virus 14-kilodalton (A27L) fusion protein forms a triple coiled-coil structure and interacts with the 21-kilodalton (A17L) virus membrane protein through a C-terminal alpha-helix.Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor.Biology of attenuated modified vaccinia virus Ankara recombinant vector in mice: virus fate and activation of B- and T-cell immune responses in comparison with the Western Reserve strain and advantages as a vaccine.The vaccinia virus 14-kilodalton fusion protein forms a stable complex with the processed protein encoded by the vaccinia virus A17L gene.Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDSDevelopment of a Safe and Effective Vaccinia Virus Oncolytic Vector WR-Δ4 with a Set of Gene Deletions on Several Viral Pathways.
P2860
Q26746915-2A2A3EC3-AE93-4C25-B4BC-358D88A378D9Q30339052-3FF8002A-66B7-44C6-8F40-C78A8D0E11CFQ33349449-FF774A61-A328-47DF-B195-4BBFCAEFFBD9Q33602820-448BDF71-8274-4A94-BA4A-E8EA23E6207CQ33604990-D7074747-7150-44BE-AF17-F41A20A7E793Q34211635-DA12A112-5D49-4BC9-93DA-587BB910BB0DQ34651266-BE9E8DFB-A63F-46F3-9902-F56CBB20AC38Q34991112-99531B21-781B-4C20-B4B5-BA543B44870AQ35947683-EC2AEC71-FD57-43B1-A611-D7099C6E7A45Q36343961-75271533-D0D7-4D3F-9B93-8DC431267540Q36655962-F99449E3-DBF7-476E-8FD0-5DBD350090BAQ36831398-5FBB38EA-DC09-497E-A486-29C1E1171BCFQ36911682-2EB12B0B-D1A2-4164-BAB5-9140D639E0D6Q37393765-52DACD8E-DCAA-43ED-B04D-5D58923A45E4Q38331459-2E0FD95A-3BD8-498B-9467-A41CE789037DQ39315677-DB3B3E09-D27A-47CA-B44C-C700F121D378Q39589039-C0E9F904-8C48-41A7-9640-262F47B6E012Q40045419-4EFAFBF8-4FEC-4B5C-85C9-E266C2454EECQ42575428-3EB52583-D7F5-4B66-995D-F8420F40B18AQ47549076-90AA3857-934B-4F8E-A7DF-91ECDBD09249
P2860
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
description
1989 nî lūn-bûn
@nan
1989 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
@ast
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
@en
type
label
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
@ast
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
@en
prefLabel
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
@ast
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
@en
P2093
P2860
P356
P1476
Highly attenuated vaccinia virus mutants for the generation of safe recombinant viruses
@en
P2093
Rodriguez D
Rodriguez JF
Rodriguez JR
P2860
P304
P356
10.1073/PNAS.86.4.1287
P407
P577
1989-02-01T00:00:00Z